Public Affairs-Associate PA Director - Shanghai
Sanofi
This listing was originally posted on Sanofi's careers page. Formulate is an equal opportunity job aggregator and is not involved in the hiring process. Where salary information is estimated, it is derived from BLS industry benchmarks and may differ from actual compensation.
Upgrade to Pro to access the AI-generated 'Read before applying' briefing and other premium pharma intelligence.
Upgrade to Pro — $25/moAbout the job
The Associate PA Director plays a transversal role within China PA, encompassing healthcare policy, government/institutional relations, and patient advocacy covering both BU-specific and company-wide topics. Reporting to the China PA Head, this individual contributor role is responsible for developing and executing public affairs strategies that support Sanofi's business objectives and strengthen the company's reputation and access agenda in China.
Key Responsibilities
1. Healthcare Policy & Government Relations
2. Public Affairs Strategy & Execution
3. Patient Advocacy & Stakeholder Engagement
4. Crisis & Issues Management
5. Cross-functional Collaboration
About you
Qualifications & Experience
Better is out there. Better medications, better outcomes, better science. But progress doesn’t happen without people – people from different backgrounds, in different locations, doing different roles, all united by one thing: a desire to make miracles happen. So, let’s be those people.
At Sanofi, we provide equal opportunities to all regardless of race, colour, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, ability or gender identity.
Watch our ALL IN video and check out our Diversity Equity and Inclusion actions at sanofi.com!
Explore related positions you might be interested in
We'll notify you when matching roles are posted.
Interviewed at Sanofi?
Help others prepare — share your experience anonymously.
PHARMACEUTICAL
Small Molecules, Biologics
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo